VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SENSSenseonics Holdings, Inc.
$6.74$282M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSENSP/E History

SENS logoSenseonics Holdings, Inc. (SENS) P/E Ratio History

Deep Value

Trading at -4.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2022–2022

Current P/E (TTM)
-4.1x
-158% vs 5Y avg
5Y Avg P/E
7.1x
Median 11.0x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
-4.1x
Min3.1xMedian11.0xMax11.0x
TTM EPS$-1.90
Price$6.74
Earnings YieldN/A
EPS Growth (1Y)33.6%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 21, 2026, Senseonics Holdings, Inc. (SENS) trades at a price-to-earnings ratio of -4.1x, with a stock price of $6.74 and trailing twelve-month earnings per share of $-1.90.

The current P/E is 158% below its 5-year average of 7.1x. Over the past five years, SENS's P/E has ranged from a low of 3.1x to a high of 11.0x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, SENS trades at a 118% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, SENS trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SENS DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

SENS Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-4.1vs22.1
-118%
Below Sector
vs. S&P 500
-4.1vs24.4
-117%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 34% EPS growth (1Y)

SENS P/E vs Peers

Diabetes care and insulin delivery peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
DXCM logoDXCMDexCom, Inc.
$28B34.73.31+47%
ABT logoABTAbbott Laboratories
$154B11.60.39Best+134%
PODD logoPODDInsulet Corporation
$10B41.90.41-40%
GMED logoGMEDGlobus Medical, Inc.
$11B20.20.65+423%
INVA logoINVAInnoviva, Inc.
$2B6.8Lowest0.66+817%Best
NVO logoNVONovo Nordisk A/S
$192B12.20.59+2%
LLY logoLLYEli Lilly and Company
$1.0T47.81.66+96%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

SENS Historical P/E Data (2022–2022)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2022 Q3Sep 30 2022$26.40$2.4011.0x+56%
FY2022 Q2-$20.60$6.603.1x-56%

Average P/E for displayed period: 7.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

4+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SENS — Frequently Asked Questions

Quick answers to the most common questions about buying SENS stock.

What is SENS's P/E ratio?

Senseonics Holdings, Inc. (SENS) trailing twelve-month P/E ratio is -4.1x, based on TTM diluted EPS of $-1.90. The 5-year average P/E is 7.1x and the historical range spans 3.1x to 11.0x.

Is SENS stock overvalued or undervalued?

SENS trades at -4.1x P/E, below its 5-year average of 7.1x. At the 0th percentile of its historical range (3.1x–11.0x), the stock is priced at a discount to its own history.

Is SENS stock expensive?

No, SENS is not expensive on a historical basis. The current P/E of -4.1x is below the 5-year average of 7.1x and sits at the 0th percentile of its valuation range.

What is SENS's historical P/E range?

Over the past 5 years, SENS's P/E ratio has ranged from 3.1x to 11.0x, with a median of 11.0x and an average of 7.1x. The current P/E of -4.1x places the stock at the 0th percentile of this range. Full historical data spans 2022–2022.

How does SENS's P/E compare to the S&P 500?

SENS trades at -4.1x P/E versus the S&P 500 median of 24.4x. The 117% discount to the market suggests lower growth expectations or perceived higher risk.

How does SENS's valuation compare to Healthcare peers?

Senseonics Holdings, Inc. P/E of -4.1x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is SENS's PEG ratio?

SENS PEG ratio is N/A, based on a P/E of -4.1x and EPS growth of 33.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is SENS's earnings yield?

SENS earnings yield is N/A, the inverse of its -4.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

SENS P/E Ratio History (2022–2022)

Quarterly valuation multiple from closing price and trailing EPS

Current11.0x
Period Avg7.1x
Range3.1x - 11.0x
Change+252%
2 quartersJun 30, 2022 - Sep 30, 2022